Abstract
Background: A series of pneumonia cases with clinical presentations of viral pneumonia secondary to new coronavirus and subsequent global transmission arose in Wuhan, Hubei, China, in December 2019. Several cases of coronavirus disease 2019 (COVID-19) have been described incidentally in positron emission tomography-computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) as a result of the pandemic. Herein, we describe the findings of a patient with unknown COVID-19 in PET/CT with the other radiopharmaceutical, 68Ga-labeled prostatespecific membrane antigen (68Ga-PSMA).
Case Report: A 69-year-old man had previously undergone radical prostatectomy for adenocarcinoma. 68Ga-PSMA PET/CT imaging was performed due to biochemical recurrence. 68Ga-PSMA uptake in the prostate bed suggestive of local recurrence was detected in PET/CT images. Also, bilateral groundglass opacities with slightly increased 68Ga-PSMA uptake were seen in the lungs, suspected of COVID-19. A reverse transcription-polymerase chain reaction test has confirmed the infection.
Conclusion: Even in asymptomatic patients, nuclear medicine departments must be aware of the possibility of COVID-19, take appropriate post-exposure procedures, and protect employees and other patients.
Keywords: Coronavirus, COVID-19, 68Ga-PSMA, PET/CT, prostate cancer, pneumonia.
Graphical Abstract
[1]
Lütje S, Marinova M, Kütting D, Attenberger U, Essler M, Bundschuh RA. Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19. Nucl Med (Stuttg) 2020; 59(3): 276-80.
[http://dx.doi.org/10.1055/a-1152-2341] [PMID: 32259853]
[http://dx.doi.org/10.1055/a-1152-2341] [PMID: 32259853]
[2]
Albano D, Bertagna F, Bertoli M, et al. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region. J Nucl Med 2020; 61(5): 632-6.
[http://dx.doi.org/10.2967/jnumed.120.246256] [PMID: 32238429]
[http://dx.doi.org/10.2967/jnumed.120.246256] [PMID: 32238429]
[3]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[4]
Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect Dis 2020; 20(4): 425-34.
[http://dx.doi.org/10.1016/S1473-3099(20)30086-4] [PMID: 32105637]
[http://dx.doi.org/10.1016/S1473-3099(20)30086-4] [PMID: 32105637]
[5]
Li G, Li W, He X, Cao Y. Asymptomatic and presymptomatic infectors: Hidden sources of coronavirus disease 2019 (COVID-19). Clin Infect Dis 2020; 71(8): 2018.
[http://dx.doi.org/10.1093/cid/ciaa418] [PMID: 32271372]
[http://dx.doi.org/10.1093/cid/ciaa418] [PMID: 32271372]
[6]
Assadi M, Gholamrezanezhad A, Jokar N, et al. Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units. Eur J Nucl Med Mol Imaging 2020; 47(8): 1779-86.
[http://dx.doi.org/10.1007/s00259-020-04780-4] [PMID: 32318782]
[http://dx.doi.org/10.1007/s00259-020-04780-4] [PMID: 32318782]
[7]
Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19) imaging reporting and data system (COVID-RADS) and common lexicon: A proposal based on the imaging data of 37 studies. Eur Radiol 2020; 30(9): 4930-42.
[http://dx.doi.org/10.1007/s00330-020-06863-0] [PMID: 32346790]
[http://dx.doi.org/10.1007/s00330-020-06863-0] [PMID: 32346790]
[8]
Qin C, Liu F, Yen TC, Lan X. 18F-FDG PET/CT findings of COVID-19: A series of four highly suspected cases. Eur J Nucl Med Mol Imaging 2020; 47(5): 1281-6.
[http://dx.doi.org/10.1007/s00259-020-04734-w] [PMID: 32088847]
[http://dx.doi.org/10.1007/s00259-020-04734-w] [PMID: 32088847]
[9]
Martineau P, Kidane B. FDG PET/CT Findings in an asymptomatic case of confirmed COVID-19. Clin Nucl Med 2020; 45(8): 647-8.
[http://dx.doi.org/10.1097/RLU.0000000000003145] [PMID: 32433160]
[http://dx.doi.org/10.1097/RLU.0000000000003145] [PMID: 32433160]
[10]
Pallardy A, Rousseau C, Labbe C, et al. Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region. Eur J Nucl Med Mol Imaging 2021; 48(1): 287-92.
[http://dx.doi.org/10.1007/s00259-020-05014-3] [PMID: 32860074]
[http://dx.doi.org/10.1007/s00259-020-05014-3] [PMID: 32860074]
[11]
Wakfie-Corieh CG, Ferrando-Castagnetto F, Blanes Garcia AM, et al. Incidental findings suggestive of COVID-19 pneumonia in oncological patients undergoing 18F-FDG PET/CT studies: Association between metabolic and structural lung changes. J Nucl Med 2021.
[http://dx.doi.org/10.2967/jnumed.121.261915]
[http://dx.doi.org/10.2967/jnumed.121.261915]
[12]
Halsey R, Priftakis D, Mackenzie S, et al. COVID-19 in the act: Incidental 18F-FDG PET/CT findings in asymptomatic patients and those with symptoms not primarily correlated with COVID-19 during the United Kingdom coronavirus lockdown. Eur J Nucl Med Mol Imaging 2021; 48(1): 269-81.
[http://dx.doi.org/10.1007/s00259-020-04972-y] [PMID: 32761260]
[http://dx.doi.org/10.1007/s00259-020-04972-y] [PMID: 32761260]
[13]
Simand C, Bund C, Guffroy B, Chaban V, Herbrecht R. Incidental discovery of a COVID-19 infection on a reevaluation FDG PET/CT in a patient treated for hodgkin lymphoma. Clin Nucl Med 2020; 45(8): 644-6.
[http://dx.doi.org/10.1097/RLU.0000000000003144] [PMID: 32520506]
[http://dx.doi.org/10.1097/RLU.0000000000003144] [PMID: 32520506]
[14]
Habouzit V, Sanchez A, Dehbi S, Prevot N, Bonnefoy PB. Incidental finding of COVID-19 lung infection in 18F-FDG PET/CT: What should we do? Clin Nucl Med 2020; 45(8): 649-51.
[http://dx.doi.org/10.1097/RLU.0000000000003135] [PMID: 32558722]
[http://dx.doi.org/10.1097/RLU.0000000000003135] [PMID: 32558722]
[15]
Mattoli MV, Taralli S, Pennese E, D’Angelo C, Angrilli F, Villano C. Atypical presentation of COVID-19 incidentally detected at 18F-FDG PET/CT in an asymptomatic oncological patient. Clin Nucl Med 2020; 45(8): e383-5.
[http://dx.doi.org/10.1097/RLU.0000000000003175] [PMID: 32520513]
[http://dx.doi.org/10.1097/RLU.0000000000003175] [PMID: 32520513]
[16]
García Vicente AM, Soriano Castrejón Á. Incidental COVID-19 pneumonia on 18F-Fluorocholine PET/CT. Clin Nucl Med 2020; 45(8): e376-7.
[http://dx.doi.org/10.1097/RLU.0000000000003189] [PMID: 32520514]
[http://dx.doi.org/10.1097/RLU.0000000000003189] [PMID: 32520514]
[17]
Stasiak CES, Cardoso FR, de Almeida SA, Rosado-de-Castro PH. Incidental finding of COVID-19 infection after [68Ga]Ga-PSMA-11 PET/CT imaging in a patient with prostate cancer. Eur J Nucl Med Mol Imaging 2021; 48(2): 653-4.
[http://dx.doi.org/10.1007/s00259-020-04932-6] [PMID: 32710224]
[http://dx.doi.org/10.1007/s00259-020-04932-6] [PMID: 32710224]
[18]
Morón S, González E, Rojas J. 68Ga-PSMA PET/CT with incidental finding of COVID-19 in an asymptomatic patient. Clin Nucl Med 2020; 45(12): 1032-3.
[http://dx.doi.org/10.1097/RLU.0000000000003388] [PMID: 33065616]
[http://dx.doi.org/10.1097/RLU.0000000000003388] [PMID: 33065616]
[19]
Karasah Erkek B, Ömür Ö, Özkök S, Turna B. COVID-19 lung findings detected by 68Ga-PSMA PET/CT for staging purposes in patients with prostate cancer. Clin Nucl Med 2022; 47(1): e17-9.
[http://dx.doi.org/10.1097/RLU.0000000000003723] [PMID: 34028424]
[http://dx.doi.org/10.1097/RLU.0000000000003723] [PMID: 34028424]
[20]
Sheikhbahaei S, Werner RA, Solnes LB, et al. Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: An update on important pitfalls. Semin Nucl Med 2019; 49(4): 255-70.
[http://dx.doi.org/10.1053/j.semnuclmed.2019.02.006] [PMID: 31227049]
[http://dx.doi.org/10.1053/j.semnuclmed.2019.02.006] [PMID: 31227049]
[21]
Damjanovic J, Janssen JC, Furth C, et al. 68 Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer. Cancer Imaging 2018; 18(1): 20.
[http://dx.doi.org/10.1186/s40644-018-0154-8] [PMID: 29769114]
[http://dx.doi.org/10.1186/s40644-018-0154-8] [PMID: 29769114]
[22]
de Galiza Barbosa F, Queiroz MA, Nunes RF, et al. Nonprostatic diseases on PSMA PET imaging: A spectrum of benign and malignant findings. Cancer Imaging 2020; 20(1): 23.
[http://dx.doi.org/10.1186/s40644-020-00300-7] [PMID: 32169115]
[http://dx.doi.org/10.1186/s40644-020-00300-7] [PMID: 32169115]
[23]
Simpson S, Kay FU, Abbara S, et al. Radiological society of North America expert consensus document on reporting chest CT findings related to COVID-19: Endorsed by the society of thoracic radiology, the american college of radiology, and RSNA. Radiol Cardiothorac Imaging 2020; 2(2)e200152
[http://dx.doi.org/10.1148/ryct.2020200152] [PMID: 33778571]
[http://dx.doi.org/10.1148/ryct.2020200152] [PMID: 33778571]
[24]
Vinjamoori AH, Jagannathan JP, Shinagare AB, et al. Atypical metastases from prostate cancer: 10-year experience at a single institution. AJR Am J Roentgenol 2012; 199(2): 367-72.
[http://dx.doi.org/10.2214/AJR.11.7533] [PMID: 22826398]
[http://dx.doi.org/10.2214/AJR.11.7533] [PMID: 22826398]
Article Metrics
8